Table 1 Demographic data about the two groups
From: Serum PYCARD may become a new diagnostic marker for rheumatoid arthritis patients
Group | M (P25, P75) | Median difference (95%CI) | Z | P | |
|---|---|---|---|---|---|
IL-38 (pg/ml) | Test group (n = 88) | 559.36 (399.29, 779.18) | 380.7 (310.51, 434.05) | 8.14 | P < 0.01 |
Control (n = 88) | 135.67 (112.97, 258.89) | ||||
PYCARD (pg/ml) | Test group (n = 88) | 1968.07 (1569.06, 2597.26) | 0.32.94 (862.18, 1236.505) | 8.83 | P < 0.01 |
Control (n = 88) | 871.82 (739.15, 1134.18) | ||||
IL-6 (ng/ml) | Test group (n = 88) | 3.58 (2.53, 4.98) | 1.78 (1.39, 2.19) | 7.50 | P < 0.01 |
Control (n = 88) | 1.62 (1.31, 2.13) | ||||
ESR (mm/h) | Test group (n = 88) | 22.5 (13, 37.5) | 14 (11, 18) | 8.82 | P < 0.01 |
Control (n = 88) | 8 (7, 10) | ||||
Anti-CCP (u/ml) | Test group (n = 88) | 228 (25.22, 499.55) | 219.1 (164.9, 300.6) | 7.42 | P < 0.01 |
Control (n = 88) | 8.4 (7.8, 9.3) |